White matter hyperintensities and changes in white matter integrity in patients with Alzheimer's disease

被引:21
|
作者
Wang, Liya [1 ,2 ]
Goldstein, Felicia C. [3 ]
Levey, Allan I. [3 ]
Lah, James J. [3 ]
Meltzer, Carolyn C. [1 ,2 ,3 ,4 ]
Holder, Chad A. [1 ]
Mao, Hui [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30329 USA
[2] Emory Univ, Sch Med, Ctr Syst Imaging, Atlanta, GA 30329 USA
[3] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA
关键词
Magnetic resonance imaging; White matter hyperintensity; Diffusion tensor; Alzheimer's disease; White matter; MILD COGNITIVE IMPAIRMENT; CORTICAL THICKNESS; VASCULAR-LESIONS; RATING-SCALE; DIFFUSION; MRI; BRAIN; ABNORMALITIES; DECLINE; ATROPHY;
D O I
10.1007/s00234-010-0806-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
White matter hyperintensities (WMHs) are a risk factor for Alzheimer's disease (AD). This study investigated the relationship between WMHs and white matter changes in AD using diffusion tensor imaging (DTI) and the sensitivity of each DTI index in distinguishing AD with WMHs. Forty-four subjects with WMHs were included. Subjects were classified into three groups based on the Scheltens rating scale: 15 AD patients with mild WMHs, 12 AD patients with severe WMHs, and 17 controls with mild WMHs. Fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (D-R), and axial diffusivity (D-A) were analyzed using the region of interest and tract-based spatial statistics methods. Sensitivity and specificity of DTI indices in distinguishing AD groups from the controls were evaluated. AD patients with mild WMHs exhibited differences from control subjects in most DTI indices in the medial temporal and frontal areas; however, differences in DTI indices from AD patients with mild WMHs and AD patients with severe WMHs were found in the parietal and occipital areas. FA and D-R were more sensitive measurements than MD and D-A in differentiating AD patients from controls, while MD was a more sensitive measurement in distinguishing AD patients with severe WMHs from those with mild WMHs. WMHs may contribute to the white matter changes in AD brains, specifically in temporal and frontal areas. Changes in parietal and occipital lobes may be related to the severity of WMHs. D-R may serve as an imaging marker of myelin deficits associated with AD.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 50 条
  • [21] Is Alzheimer's a disease of the white matter?
    Sachdev, Perminder S.
    Zhuang, Lin
    Braidy, Nady
    Wen, Wei
    CURRENT OPINION IN PSYCHIATRY, 2013, 26 (03) : 244 - 251
  • [22] White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution
    Garnier-Crussard, Antoine
    Cotton, Francois
    Krolak-Salmon, Pierre
    Chetelat, Gael
    ALZHEIMERS & DEMENTIA, 2023, 19 (08) : 3738 - 3748
  • [23] Contemplating Alzheimer’s Disease and the Contribution of White Matter Hyperintensities
    Adam M. Brickman
    Current Neurology and Neuroscience Reports, 2013, 13
  • [24] White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease
    Desmarais, Philippe
    Gao, Andrew F.
    Lanctot, Krista
    Rogaeva, Ekaterina
    Ramirez, Joel
    Herrmann, Nathan
    Stuss, Donald T.
    Black, Sandra E.
    Keith, Julia
    Masellis, Mario
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [25] Discriminative patterns of white matter changes in Alzheimer's
    Srivishagan, Subaramya
    Kumaralingam, Logiraj
    Thanikasalam, Kokul
    Pinidiyaarachchi, U. A. J.
    Ratnarajah, Nagulan
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2023, 328
  • [26] Interplay Between Macular Retinal Changes and White Matter Integrity in Early Alzheimer's Disease
    Alves, Carolina
    Jorge, Lilia
    Canario, Nadia
    Santiago, Beatriz
    Santana, Isabel
    Castelhano, Joao
    Ambrosio, Antonio Francisco
    Bernardes, Rui
    Castelo-Branco, Miguel
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 70 (03) : 723 - 732
  • [27] White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease
    Misquitta, Karen
    Dadar, Mahsa
    Collins, D. Louis
    Tartaglia, Maria Carmela
    NEUROIMAGE-CLINICAL, 2020, 28
  • [28] White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers
    van Doorn, Linda J. C. van Waalwijk
    Ghafoorian, Mohsen
    van Leijsen, Esther M. C.
    Claassen, Jurgen A. H. R.
    Arighi, Andrea
    Bozzali, Marco
    Cannas, Jorge
    Cavedo, Enrica
    Eusebi, Paolo
    Farotti, Lucia
    Fenoglio, Chiara
    Fortea, Juan
    Frisoni, Giovanni B.
    Galimberti, Daniela
    Greco, Viviana
    Herukka, Sanna-Kaisa
    Liu, Yawu
    Lleo, Alberto
    de Mendonca, Alexandre
    Nobili, Flavio M.
    Parnetti, Lucilla
    Picco, Agnese
    Pikkarainen, Maria
    Salvadori, Nicola
    Scarpini, Elio
    Soininen, Hilkka
    Tarducci, Roberto
    Urbani, Andrea
    Vilaplana, Eduard
    Meulenbroek, Olga
    Platel, Bram
    Verbeek, Marcel M.
    Kuiperij, H. Bea
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (01) : 163 - 175
  • [29] Molecular profiling of frontal and occipital subcortical white matter hyperintensities in Alzheimer's disease
    Malla, Sulochan
    Bryant, Annie G.
    Jayakumar, Rojashree
    Woost, Benjamin
    Wolf, Nina
    Li, Andrew
    Das, Sudeshna
    van Veluw, Susanne J.
    Bennett, Rachel E.
    FRONTIERS IN NEUROLOGY, 2025, 15
  • [30] White matter integrity and vulnerability to Alzheimer's disease: Preliminary findings and future directions
    Gold, Brian T.
    Johnson, Nathan F.
    Powell, David K.
    Smith, Charles D.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03): : 416 - 422